Free Trial

Establishment Labs (ESTA) Competitors

Establishment Labs logo
$43.97 -2.14 (-4.64%)
Closing price 07/8/2025 04:00 PM Eastern
Extended Trading
$43.76 -0.20 (-0.47%)
As of 07/8/2025 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ESTA vs. NARI, TMDX, BLCO, SLNO, INSP, NVST, PRCT, LIVN, WRBY, and NVCR

Should you be buying Establishment Labs stock or one of its competitors? The main competitors of Establishment Labs include Inari Medical (NARI), TransMedics Group (TMDX), Bausch + Lomb (BLCO), Soleno Therapeutics (SLNO), Inspire Medical Systems (INSP), Envista (NVST), PROCEPT BioRobotics (PRCT), LivaNova (LIVN), Warby Parker (WRBY), and NovoCure (NVCR). These companies are all part of the "medical equipment" industry.

Establishment Labs vs. Its Competitors

Inari Medical (NASDAQ:NARI) and Establishment Labs (NASDAQ:ESTA) are both medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their dividends, earnings, media sentiment, valuation, institutional ownership, profitability, risk and analyst recommendations.

91.0% of Inari Medical shares are held by institutional investors. Comparatively, 72.9% of Establishment Labs shares are held by institutional investors. 10.6% of Inari Medical shares are held by insiders. Comparatively, 11.4% of Establishment Labs shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.

Inari Medical has a net margin of -13.68% compared to Establishment Labs' net margin of -52.34%. Inari Medical's return on equity of -10.09% beat Establishment Labs' return on equity.

Company Net Margins Return on Equity Return on Assets
Inari Medical-13.68% -10.09% -6.60%
Establishment Labs -52.34%-196.25%-26.64%

In the previous week, Establishment Labs had 2 more articles in the media than Inari Medical. MarketBeat recorded 2 mentions for Establishment Labs and 0 mentions for Inari Medical. Establishment Labs' average media sentiment score of 0.34 beat Inari Medical's score of 0.00 indicating that Establishment Labs is being referred to more favorably in the news media.

Company Overall Sentiment
Inari Medical Neutral
Establishment Labs Neutral

Inari Medical has higher revenue and earnings than Establishment Labs. Inari Medical is trading at a lower price-to-earnings ratio than Establishment Labs, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Inari Medical$493.63M9.48-$1.64M-$1.35-59.24
Establishment Labs$166.02M7.66-$84.60M-$3.10-14.18

Inari Medical currently has a consensus price target of $69.22, indicating a potential downside of 13.44%. Establishment Labs has a consensus price target of $52.40, indicating a potential upside of 19.17%. Given Establishment Labs' stronger consensus rating and higher probable upside, analysts plainly believe Establishment Labs is more favorable than Inari Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Inari Medical
0 Sell rating(s)
12 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.14
Establishment Labs
0 Sell rating(s)
1 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.80

Inari Medical has a beta of 1.02, suggesting that its share price is 2% more volatile than the S&P 500. Comparatively, Establishment Labs has a beta of 0.8, suggesting that its share price is 20% less volatile than the S&P 500.

Summary

Inari Medical beats Establishment Labs on 9 of the 16 factors compared between the two stocks.

Get Establishment Labs News Delivered to You Automatically

Sign up to receive the latest news and ratings for ESTA and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ESTA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ESTA vs. The Competition

MetricEstablishment LabsMedical Services IndustryMedical SectorNASDAQ Exchange
Market Cap$1.33B$7.24B$5.47B$8.95B
Dividend YieldN/A2.83%5.25%4.04%
P/E Ratio-14.1827.3326.9620.11
Price / Sales7.6634.17430.20119.79
Price / CashN/A23.6936.8257.86
Price / Book23.146.727.985.56
Net Income-$84.60M$230.16M$3.16B$248.40M
7 Day Performance-0.88%1.12%2.39%4.67%
1 Month Performance14.24%2.31%2.18%6.64%
1 Year Performance-0.72%49.95%33.82%21.31%

Establishment Labs Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ESTA
Establishment Labs
1.2076 of 5 stars
$43.97
-4.6%
$52.40
+19.2%
-2.2%$1.33B$166.02M-14.181,018
NARI
Inari Medical
N/A$79.97
flat
$69.22
-13.4%
N/A$4.68B$493.63M-59.24800
TMDX
TransMedics Group
1.6918 of 5 stars
$134.01
+1.9%
$127.33
-5.0%
-16.4%$4.45B$441.54M98.54210
BLCO
Bausch + Lomb
3.1036 of 5 stars
$13.03
+5.1%
$15.54
+19.3%
-8.2%$4.39B$4.79B-12.6513,500Analyst Forecast
High Trading Volume
SLNO
Soleno Therapeutics
4.7672 of 5 stars
$83.78
+0.6%
$107.10
+27.8%
+101.0%$4.20BN/A-18.1330
INSP
Inspire Medical Systems
4.8288 of 5 stars
$129.28
-2.4%
$211.91
+63.9%
-1.7%$3.91B$802.80M59.581,246News Coverage
Positive News
NVST
Envista
3.8163 of 5 stars
$19.58
-0.5%
$20.23
+3.3%
+22.8%$3.33B$2.51B-3.0012,300
PRCT
PROCEPT BioRobotics
2.6677 of 5 stars
$57.60
+1.2%
$90.00
+56.3%
-9.8%$3.15B$224.50M-33.88430Analyst Forecast
LIVN
LivaNova
3.2051 of 5 stars
$45.02
-1.6%
$59.29
+31.7%
-9.6%$2.49B$1.25B-11.012,900Positive News
WRBY
Warby Parker
1.9588 of 5 stars
$21.94
+0.2%
$22.88
+4.3%
+45.0%$2.29B$771.32M-182.833,780
NVCR
NovoCure
3.5853 of 5 stars
$17.80
-1.1%
$32.83
+84.5%
+9.4%$2.01B$605.22M-11.791,488Analyst Forecast

Related Companies and Tools


This page (NASDAQ:ESTA) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners